CN Stock MarketDetailed Quotes

002462 Cachet Pharmaceutical

Watchlist
  • 12.74
  • +0.92+7.78%
Market Closed Sep 30 15:00 CST
3.72BMarket Cap14.14P/E (TTM)

Cachet Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-13.70%12.84B
10.17%7.44B
14.40%30B
7.43%21.79B
17.09%14.88B
4.57%6.76B
2.32%26.22B
4.81%20.28B
1.15%12.71B
11.19%6.46B
Operating revenue
-13.70%12.84B
10.17%7.44B
14.40%30B
7.43%21.79B
17.09%14.88B
4.57%6.76B
2.32%26.22B
4.81%20.28B
1.15%12.71B
11.19%6.46B
Other operating revenue
7.54%96.53M
----
--0
----
-4.54%89.77M
----
--0
----
54.54%94.04M
----
Total operating cost
-13.36%12.58B
10.22%7.29B
14.81%29.27B
7.64%21.25B
17.27%14.52B
4.96%6.61B
2.88%25.49B
5.36%19.74B
1.79%12.38B
11.79%6.3B
Operating cost
-12.95%12.06B
11.73%7.02B
16.20%28.02B
8.00%20.27B
18.49%13.85B
5.65%6.29B
2.67%24.11B
5.77%18.77B
1.49%11.69B
12.15%5.95B
Operating tax surcharges
15.60%28.64M
13.43%11.09M
11.79%51.2M
7.95%38.13M
6.60%24.77M
4.95%9.78M
2.38%45.8M
9.38%35.32M
17.88%23.24M
13.69%9.32M
Operating expense
-30.08%281.46M
-23.83%149.24M
-13.17%724.91M
5.67%593.1M
-4.57%402.55M
-11.67%195.92M
4.31%834.82M
-10.18%561.28M
3.48%421.81M
3.04%221.8M
Administration expense
-6.62%145.95M
-7.80%74.4M
2.51%326.6M
-3.46%228.21M
2.04%156.3M
5.30%80.69M
10.68%318.61M
13.60%236.39M
17.34%153.18M
16.82%76.63M
Financial expense
-21.70%62.63M
-23.13%32.01M
-19.61%143.87M
-12.52%115.55M
-9.44%79.99M
-2.69%41.64M
12.62%178.97M
8.17%132.08M
4.81%88.33M
0.67%42.79M
-Interest expense (Financial expense)
----
----
-11.35%155.42M
----
----
----
14.76%175.31M
----
----
----
-Interest Income (Financial expense)
----
----
-38.75%-31.12M
----
----
----
-31.01%-22.43M
----
----
----
Research and development
----
----
----
----
----
----
----
--2.72M
--1.78M
--863.22K
Credit Impairment Loss
-11.63%-52.61M
21.50%-13.26M
-13.71%-104.47M
-5.24%-53.51M
-106.70%-47.13M
-110.96%-16.89M
-235.36%-91.88M
-274.70%-50.85M
-1,971.28%-22.8M
-149.30%-8M
Asset Impairment Loss
154.36%11.29M
356.89%3.87M
-316.20%-98.3M
-258.06%-27.6M
-223.01%-20.77M
-172.50%-1.51M
-8.82%-23.62M
5.31%17.46M
23.09%16.88M
--2.08M
Other net revenue
347.70%123.17M
71.20%-2.49M
-120.50%-174.78M
-6,262.89%-59.62M
-387.22%-49.72M
-207.79%-8.64M
-336.38%-79.26M
-103.27%-936.96K
-49.74%17.31M
-68.68%8.02M
Fair value change income
138.10%5.97K
381.82%23.13K
61.80%-25.36K
73.44%-25.36K
70.00%-15.67K
60.42%-8.21K
87.12%-66.39K
---95.49K
---52.22K
---20.73K
Invest income
186.04%427.53K
201.28%239.8K
-35.19%-3.47M
-471.21%-617.52K
-447.96%-496.9K
---236.77K
-266.81%-2.57M
--166.35K
---90.68K
----
-Including: Investment income associates
----
----
82.47%92.16K
----
----
----
-32.94%50.51K
----
----
----
Asset deal income
74,181.90%157.16M
1,305.81%201.59K
-49.40%845.56K
31.33%592.01K
574.60%211.57K
-159.93%-16.72K
126.15%1.67M
41.04%450.79K
-93.06%31.36K
-92.11%27.9K
Other revenue
-62.64%6.9M
-35.72%6.44M
-17.60%30.65M
-32.51%21.55M
-20.85%18.48M
-28.15%10.01M
27.50%37.2M
26.25%31.92M
22.50%23.34M
54.77%13.94M
Operating profit
23.53%384.96M
12.90%150.51M
-14.42%556.36M
-11.07%482.77M
-9.60%311.64M
-20.24%133.32M
-21.75%650.1M
-16.01%542.89M
-20.81%344.73M
-16.13%167.15M
Add:Non operating Income
128.72%3M
3,437.83%11.57M
126.70%2.62M
42.30%1.49M
221.19%1.31M
29.78%327.01K
22.72%1.16M
79.80%1.05M
194.77%408.98K
-94.58%251.97K
Less:Non operating expense
253.19%4.91M
-32.43%502.81K
-41.71%3.7M
-64.64%1.74M
-35.85%1.39M
94.71%744.08K
-17.87%6.35M
-10.21%4.92M
-53.96%2.17M
-79.66%382.15K
Total profit
22.95%383.06M
21.58%161.58M
-13.90%555.28M
-10.48%482.53M
-9.16%311.56M
-20.43%132.9M
-21.73%644.91M
-15.97%539.02M
-20.38%342.97M
-17.34%167.02M
Less:Income tax cost
63.03%130.35M
25.27%44.22M
1.22%178.75M
-12.10%122.83M
-8.10%79.96M
-22.62%35.3M
-20.49%176.59M
-19.91%139.74M
-27.21%87M
-20.20%45.62M
Net profit
9.11%252.7M
20.24%117.35M
-19.60%376.53M
-9.91%359.69M
-9.52%231.6M
-19.61%97.6M
-22.19%468.31M
-14.50%399.27M
-17.76%255.97M
-16.21%121.4M
Net profit from continuing operation
9.11%252.7M
20.24%117.35M
-19.60%376.53M
-9.91%359.69M
-9.52%231.6M
-19.61%97.6M
-22.19%468.31M
-14.50%399.27M
-17.76%255.97M
-16.21%121.4M
Less:Minority Profit
11.00%84.48M
40.04%41.82M
-26.20%126.47M
-19.27%122.83M
-11.99%76.11M
-29.83%29.86M
-30.90%171.38M
-24.45%152.15M
-36.45%86.48M
-32.51%42.56M
Net profit of parent company owners
8.19%168.22M
11.51%75.53M
-15.79%250.06M
-4.15%236.86M
-8.26%155.49M
-14.08%67.73M
-16.09%296.94M
-6.96%247.12M
-3.24%169.49M
-3.65%78.84M
Earning per share
Basic earning per share
9.43%0.58
11.50%0.2589
-15.69%0.86
-4.71%0.81
-8.62%0.53
-14.00%0.2322
-15.70%1.02
-6.59%0.85
-3.33%0.58
-3.57%0.27
Diluted earning per share
9.43%0.58
11.50%0.2589
-15.69%0.86
-4.71%0.81
-8.62%0.53
-14.00%0.2322
-15.70%1.02
-6.59%0.85
-3.33%0.58
-3.57%0.27
Other composite income
Total composite income
9.11%252.7M
20.24%117.35M
-19.60%376.53M
-9.91%359.69M
-9.52%231.6M
-19.61%97.6M
-22.19%468.31M
-14.50%399.27M
-17.76%255.97M
-16.21%121.4M
Total composite income of parent company owners
8.19%168.22M
11.51%75.53M
-15.79%250.06M
-4.15%236.86M
-8.26%155.49M
-14.08%67.73M
-16.09%296.94M
-6.96%247.12M
-3.24%169.49M
-3.65%78.84M
Total composite income of minority owners
11.00%84.48M
40.04%41.82M
-26.20%126.47M
-19.27%122.83M
-11.99%76.11M
-29.83%29.86M
-30.90%171.38M
-24.45%152.15M
-36.45%86.48M
-32.51%42.56M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -13.70%12.84B10.17%7.44B14.40%30B7.43%21.79B17.09%14.88B4.57%6.76B2.32%26.22B4.81%20.28B1.15%12.71B11.19%6.46B
Operating revenue -13.70%12.84B10.17%7.44B14.40%30B7.43%21.79B17.09%14.88B4.57%6.76B2.32%26.22B4.81%20.28B1.15%12.71B11.19%6.46B
Other operating revenue 7.54%96.53M------0-----4.54%89.77M------0----54.54%94.04M----
Total operating cost -13.36%12.58B10.22%7.29B14.81%29.27B7.64%21.25B17.27%14.52B4.96%6.61B2.88%25.49B5.36%19.74B1.79%12.38B11.79%6.3B
Operating cost -12.95%12.06B11.73%7.02B16.20%28.02B8.00%20.27B18.49%13.85B5.65%6.29B2.67%24.11B5.77%18.77B1.49%11.69B12.15%5.95B
Operating tax surcharges 15.60%28.64M13.43%11.09M11.79%51.2M7.95%38.13M6.60%24.77M4.95%9.78M2.38%45.8M9.38%35.32M17.88%23.24M13.69%9.32M
Operating expense -30.08%281.46M-23.83%149.24M-13.17%724.91M5.67%593.1M-4.57%402.55M-11.67%195.92M4.31%834.82M-10.18%561.28M3.48%421.81M3.04%221.8M
Administration expense -6.62%145.95M-7.80%74.4M2.51%326.6M-3.46%228.21M2.04%156.3M5.30%80.69M10.68%318.61M13.60%236.39M17.34%153.18M16.82%76.63M
Financial expense -21.70%62.63M-23.13%32.01M-19.61%143.87M-12.52%115.55M-9.44%79.99M-2.69%41.64M12.62%178.97M8.17%132.08M4.81%88.33M0.67%42.79M
-Interest expense (Financial expense) ---------11.35%155.42M------------14.76%175.31M------------
-Interest Income (Financial expense) ---------38.75%-31.12M-------------31.01%-22.43M------------
Research and development ------------------------------2.72M--1.78M--863.22K
Credit Impairment Loss -11.63%-52.61M21.50%-13.26M-13.71%-104.47M-5.24%-53.51M-106.70%-47.13M-110.96%-16.89M-235.36%-91.88M-274.70%-50.85M-1,971.28%-22.8M-149.30%-8M
Asset Impairment Loss 154.36%11.29M356.89%3.87M-316.20%-98.3M-258.06%-27.6M-223.01%-20.77M-172.50%-1.51M-8.82%-23.62M5.31%17.46M23.09%16.88M--2.08M
Other net revenue 347.70%123.17M71.20%-2.49M-120.50%-174.78M-6,262.89%-59.62M-387.22%-49.72M-207.79%-8.64M-336.38%-79.26M-103.27%-936.96K-49.74%17.31M-68.68%8.02M
Fair value change income 138.10%5.97K381.82%23.13K61.80%-25.36K73.44%-25.36K70.00%-15.67K60.42%-8.21K87.12%-66.39K---95.49K---52.22K---20.73K
Invest income 186.04%427.53K201.28%239.8K-35.19%-3.47M-471.21%-617.52K-447.96%-496.9K---236.77K-266.81%-2.57M--166.35K---90.68K----
-Including: Investment income associates --------82.47%92.16K-------------32.94%50.51K------------
Asset deal income 74,181.90%157.16M1,305.81%201.59K-49.40%845.56K31.33%592.01K574.60%211.57K-159.93%-16.72K126.15%1.67M41.04%450.79K-93.06%31.36K-92.11%27.9K
Other revenue -62.64%6.9M-35.72%6.44M-17.60%30.65M-32.51%21.55M-20.85%18.48M-28.15%10.01M27.50%37.2M26.25%31.92M22.50%23.34M54.77%13.94M
Operating profit 23.53%384.96M12.90%150.51M-14.42%556.36M-11.07%482.77M-9.60%311.64M-20.24%133.32M-21.75%650.1M-16.01%542.89M-20.81%344.73M-16.13%167.15M
Add:Non operating Income 128.72%3M3,437.83%11.57M126.70%2.62M42.30%1.49M221.19%1.31M29.78%327.01K22.72%1.16M79.80%1.05M194.77%408.98K-94.58%251.97K
Less:Non operating expense 253.19%4.91M-32.43%502.81K-41.71%3.7M-64.64%1.74M-35.85%1.39M94.71%744.08K-17.87%6.35M-10.21%4.92M-53.96%2.17M-79.66%382.15K
Total profit 22.95%383.06M21.58%161.58M-13.90%555.28M-10.48%482.53M-9.16%311.56M-20.43%132.9M-21.73%644.91M-15.97%539.02M-20.38%342.97M-17.34%167.02M
Less:Income tax cost 63.03%130.35M25.27%44.22M1.22%178.75M-12.10%122.83M-8.10%79.96M-22.62%35.3M-20.49%176.59M-19.91%139.74M-27.21%87M-20.20%45.62M
Net profit 9.11%252.7M20.24%117.35M-19.60%376.53M-9.91%359.69M-9.52%231.6M-19.61%97.6M-22.19%468.31M-14.50%399.27M-17.76%255.97M-16.21%121.4M
Net profit from continuing operation 9.11%252.7M20.24%117.35M-19.60%376.53M-9.91%359.69M-9.52%231.6M-19.61%97.6M-22.19%468.31M-14.50%399.27M-17.76%255.97M-16.21%121.4M
Less:Minority Profit 11.00%84.48M40.04%41.82M-26.20%126.47M-19.27%122.83M-11.99%76.11M-29.83%29.86M-30.90%171.38M-24.45%152.15M-36.45%86.48M-32.51%42.56M
Net profit of parent company owners 8.19%168.22M11.51%75.53M-15.79%250.06M-4.15%236.86M-8.26%155.49M-14.08%67.73M-16.09%296.94M-6.96%247.12M-3.24%169.49M-3.65%78.84M
Earning per share
Basic earning per share 9.43%0.5811.50%0.2589-15.69%0.86-4.71%0.81-8.62%0.53-14.00%0.2322-15.70%1.02-6.59%0.85-3.33%0.58-3.57%0.27
Diluted earning per share 9.43%0.5811.50%0.2589-15.69%0.86-4.71%0.81-8.62%0.53-14.00%0.2322-15.70%1.02-6.59%0.85-3.33%0.58-3.57%0.27
Other composite income
Total composite income 9.11%252.7M20.24%117.35M-19.60%376.53M-9.91%359.69M-9.52%231.6M-19.61%97.6M-22.19%468.31M-14.50%399.27M-17.76%255.97M-16.21%121.4M
Total composite income of parent company owners 8.19%168.22M11.51%75.53M-15.79%250.06M-4.15%236.86M-8.26%155.49M-14.08%67.73M-16.09%296.94M-6.96%247.12M-3.24%169.49M-3.65%78.84M
Total composite income of minority owners 11.00%84.48M40.04%41.82M-26.20%126.47M-19.27%122.83M-11.99%76.11M-29.83%29.86M-30.90%171.38M-24.45%152.15M-36.45%86.48M-32.51%42.56M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data